Skip to main content

Lincotek

ApplicationRubbiano, ItalyFounded 1973· One of 356 Application companies tracked by AMPulse

Vertically integrated contract manufacturer providing end-to-end additive manufacturing services for medical implants, including design, prototyping, serial production, coating, and final assembly.

CEO / Founder
Andrea Colombo
Team Size
1001-5000
Stage
Established
Total Funding
$26.4M
Latest Round
Acquired
Key Investors
Eagle Capital Ventures; The Equity Club

Technology & Products

Key Products

SportLinc Syndesmosis Device (FDA 510(k) cleared); 3D-printed orthopedic screws (patented); Cervical spine implant systems; Custom orthopedic implants; Surface coating solutions (e.g., HAnano technology)

Technological Advantage

Proprietary metal AM processes for medical implants, validated through FDA 510(k) clearances (e.g., K252081 for SportLinc) and patents (e.g., for 3D-printed orthopedic screws). Vertically integrated model with in-house coating and finishing reduces supply chain complexity and ensures quality control, protected by trade secrets and regulatory approvals.

Differentiation

Value Proposition

Reduces time-to-market for trauma and sports medicine products by providing FDA-cleared predicate devices (e.g., SportLinc Syndesmosis Device) and full-service manufacturing, enabling partners to bypass significant regulatory hurdles and achieve faster commercialization.

How They Differentiate

Unlike pure-play AM bureaus, Lincotek offers full vertical integration including forging, casting, machining, and proprietary surface coatings alongside metal AM, reducing lead times and providing regulatory-ready implant systems. Its FDA-cleared predicate devices (e.g., SportLinc) provide a unique regulatory shortcut for OEM partners.

Market & Competition

Target Customers

Orthopedic Original Equipment Manufacturers (OEMs), medical device companies, and healthcare providers

Industry Verticals

Medical; Aerospace; Energy

Competitors

Materialise; 3D Systems (Healthcare division); Stryker (AMMG); Smith & Nephew (Additive Manufacturing)

Growth & Milestones

Growth Metrics

Operates about 40 industrial 3D printers across facilities in Memphis, TN, USA, and Trento, Italy; Aims to produce 100,000 medical 3D printed parts per year

Major Milestones

1973: Company founded; 2020: Rebranded as Lincotek; 2023: Celebrated 50th anniversary; 2024: FDA 510(k) clearance for SportLinc Syndesmosis Device (K252081); 2024: Patent secured for 3D-printed orthopedic screw; 2026: Appointment of new Global General Manager for Medical Division

Notable Customers

Johnson & Johnson; Stryker; Zimmer Biomet; Smith+Nephew; Medtronic; Globus Medical; NuVasive; Orthofix; Wright Medical; Exactech; Arthrex; Corin; LimaCorporate; Medacta; Aesculap; DJO Global; ConforMIS; FH Orthopedics; Integra LifeSciences; Össur

Recent coverage of Lincotek